Share on StockTwits

Shares of Neuralstem (NYSE:CUR) saw a significant increase in short interest in August. As of August 15th, there was short interest totalling 10,121,431 shares, an increase of 1.4% from the July 31st total of 9,983,880 shares, reports. Currently, 12.2% of the company’s stock are sold short. Based on an average daily volume of 593,005 shares, the days-to-cover ratio is presently 17.1 days.

CUR has been the subject of a number of recent research reports. Analysts at Aegis reiterated a “buy” rating on shares of Neuralstem in a research note on Friday, August 8th.

Shares of Neuralstem (NYSE:CUR) opened at 3.63 on Wednesday. Neuralstem has a one year low of $1.55 and a one year high of $4.81. The stock’s 50-day moving average is $3.31 and its 200-day moving average is $3.75. The company’s market cap is $315.2 million.

Neuralstem (NYSE:CUR) last announced its earnings results on Friday, August 8th. The company reported ($0.08) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.05) by $0.03. On average, analysts predict that Neuralstem will post $-0.22 earnings per share for the current fiscal year.

Neuralstem, Inc is a development-stage company focused on the development and commercialization of treatments for central nervous system disease based on transplanting human neural stems cells and the use of small molecule drugs.

Receive News & Ratings for Neuralstem Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neuralstem Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.